Aug 03, 2023 / 12:30PM GMT
Operator
Good morning, ladies and gentlemen, and welcome to the Fennec Pharmaceuticals second-quarter 2023 earnings and corporate update conference call. (Operator Instructions) As a reminder, today's conference call is being recorded.
Now, I would like to turn the conference over to Fennec's Chief Financial Officer, Robert Andrade.
Robert Andrade - Fennec Pharmaceuticals Inc. - CFO
Thank you, operator, and good morning, everyone. We are delighted that you can join us today for Fennec Pharmaceuticals' second-quarter 2023 earnings conference call, during which we will review our financial results as well as provide a general business update. Joining me from Fennec this morning is Rosty Raykov, our Chief Executive Officer; and our newly appointed Chief Operating Officer, Adrian Haigh.
Before we begin, I would like to remind you that during this call, the company will be making forward-looking statements that are subject to risks and uncertainties that may cause actual results to differ from the results discussed in the forward-looking statements.
Q2 2023 Fennec Pharmaceuticals Inc Earnings Call Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers